Foresite Capital Management V, LLC Lyell Immunopharma, Inc. Transaction History
Foresite Capital Management V, LLC
- $35.9 Million
- Q4 2024
A detailed history of Foresite Capital Management V, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Foresite Capital Management V, LLC holds 8,133,047 shares of LYEL stock, worth $5.69 Million. This represents 14.48% of its overall portfolio holdings.
Number of Shares
8,133,047Holding current value
$5.69 Million% of portfolio
14.48%Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
108Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$14.1 Million17.35% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$10.6 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$10.6 Million14.08% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$9.45 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$8.34 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $173M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...